Novel Tumor Targeting

• Uses antigens (markers on cells) to specifically target cells that express the marker, including cancer cells, with therapeutic agents.¹
• The ideal antigen is present on cancer cells but not on normal cells.¹
  

AbbVie leverages its expertise across multiple technology platforms to identify novel antigens and approaches needed to target them.

[1] Alatrash G, Crain, A, et al. Chapter 7 – Tumor-Associated Antigens. Immune Biologic Allogeneic Hematopoeitic Stem cell Transplantation. 2019(2):107-125.